Liver Liquescence Liquid
NDC Package 83027-0101-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Liver Liquescence (carduus marianus, chelidonium majus, lappa major, uva ursi, raphanus sativus, taraxacum officinale, lycopodium clavatum, hydrastis canadensis, gallbladder (bovine), hepar (bovine), beta vulgaris, phosphorus) liquids is adults 1 to 2 teaspoons one to two times daily. This formulation utilizes a liquid delivery system. Marketed by Nutritional Specialties, Inc., this product is identified by NDC 83027-0101.

Identification & Billing

NDC Package Code
83027-0101-1
Package Description
120 mL in 1 BOTTLE, GLASS
Product Code
11-Digit Billing Format
83027010101

Clinical Specifications

Proprietary Name
Liver Liquescence
Non-Proprietary Name
Carduus Marianus, Chelidonium Majus, Lappa Major, Uva Ursi, Raphanus Sativus, Taraxacum Officinale, Lycopodium Clavatum, Hydrastis Canadensis, Gallbladder (bovine), Hepar (bovine), Beta Vulgaris, Phosphorus
Substance Name
Arctium Lappa Root; Arctostaphylos Uva-ursi Leaf; Beta Vulgaris Whole; Bos Taurus Gallbladder; Chelidonium Majus Whole; Goldenseal; Heparin, Bovine; Lycopodium Clavatum Spore; Milk Thistle; Phosphorus; Radish; Taraxacum Officinale
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Adults 1 to 2 teaspoons one to two times daily. Children under twelve one half adult dosage. Consult a physician for use in children under 12 years of age.

Regulatory & Marketing

Labeler Name
Nutritional Specialties, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
09-11-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83027-0101-1 identifies a specific commercial package of 120 ml in 1 bottle, glass of Liver Liquescence, a human over the counter drug labeled by Nutritional Specialties, Inc.. This liquid is formulated for oral use and contains arctium lappa root; arctostaphylos uva-ursi leaf; beta vulgaris whole; bos taurus gallbladder; chelidonium majus whole; goldenseal; heparin, bovine; lycopodium clavatum spore; milk thistle; phosphorus; radish; taraxacum officinale as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nutritional Specialties, Inc. on September 11, 2023. The current certification is valid through December 31, 2026.

How is this Nutritional Specialties, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83027010101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
83027-0101-1
11-Digit CMS (5-4-2)
83027-0101-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.